UNI-EN 8:RESULTS FOR NOVEMBER 2011
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 8 | / | 2011 | | ||||||
| Date of issue: | 2011-12-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| RESULTS FOR NOVEMBER 2011 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| In compliance with the provisions of article 100к., para 1, from the Law on Public Offering of Securities we advise you that for the month of November 2011 "SOPHARMA" AD has decrease in revenues from sales with 23% in comparison with the same month of the previous year, including same levels of domestic sales and 29% decrese in exports. Revenues for the eleven months of this year decrease with 2%, including 1% decrease on the domestic market and 2% decrease of export sales compared to the same period of 2010. In compliance with the provisions of article 100к, para 1 from the Law on Public Offering of Securities please make the above information public. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | nd | ||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2011-12-05 | Ognian Donev | Chairman of the Board of Directors | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
